$BKSY
BlackSky Technology Inc.

2019 Q4 Form 10-Q Financial Statement

#000119312519311664 Filed on December 11, 2019

View on sec.gov

Income Statement

Concept 2019 Q4 2019 Q3 2018 Q4
Revenue
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses
YoY Change
Operating Profit -$1.061K
YoY Change
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$1.061K
YoY Change
Income Tax
% Of Pretax Income
Net Earnings -$1.061K
YoY Change
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share
COMMON SHARES
Basic Shares Outstanding 39.53M
Diluted Shares Outstanding

Balance Sheet

Concept 2019 Q4 2019 Q3 2018 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $37.19M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses $202.5K
Receivables
Other Receivables
Total Short-Term Assets $1.286M $42.06K
YoY Change 2957.66%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $317.0M $172.3K
YoY Change 183882.7%
TOTAL ASSETS
Total Short-Term Assets $1.286M $42.06K
Total Long-Term Assets $317.0M $172.3K
Total Assets $318.2M $471.4K $214.3K
YoY Change 148378.55%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses $1.853K $1.488K
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $276.4K $451.4K $191.5K
YoY Change 44.31%
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $276.4K $451.4K $191.5K
Total Long-Term Liabilities
Total Liabilities $11.35M $191.5K
YoY Change 5823.88%
SHAREHOLDERS EQUITY
Retained Earnings $348.7K -$5.058K -$2.177K
YoY Change -16118.19%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$18.30M $19.94K $22.82K
YoY Change
Total Liabilities & Shareholders Equity $318.2M $471.4K $214.3K
YoY Change 148378.55%

Cashflow Statement

Concept 2019 Q4 2019 Q3 2018 Q4
OPERATING ACTIVITIES
Net Income -$1.061K
YoY Change
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities
YoY Change
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities
YoY Change
NET CHANGE
Cash From Operating Activities
Cash From Investing Activities
Cash From Financing Activities
Net Change In Cash
YoY Change
FREE CASH FLOW
Cash From Operating Activities
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2019Q3 us-gaap Cash
Cash
35405
CY2018Q4 us-gaap Cash
Cash
42061
CY2019Q3 us-gaap Deferred Offering Costs
DeferredOfferingCosts
435983
CY2018Q4 us-gaap Deferred Offering Costs
DeferredOfferingCosts
172277
CY2019Q3 us-gaap Assets
Assets
471388
CY2018Q4 us-gaap Assets
Assets
214338
CY2019Q3 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
1061
us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
2881
dei Document Type
DocumentType
10-Q
dei Entity Address State Or Province
EntityAddressStateOrProvince
PA
CY2019Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1853
CY2018Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1488
CY2019Q3 sftwu Accrued Offering Costs Current
AccruedOfferingCostsCurrent
261993
CY2018Q4 sftwu Accrued Offering Costs Current
AccruedOfferingCostsCurrent
90027
CY2019Q3 us-gaap Notes Payable Related Parties Classified Current
NotesPayableRelatedPartiesClassifiedCurrent
187600
CY2018Q4 us-gaap Notes Payable Related Parties Classified Current
NotesPayableRelatedPartiesClassifiedCurrent
100000
CY2019Q3 us-gaap Liabilities Current
LiabilitiesCurrent
451446
CY2018Q4 us-gaap Liabilities Current
LiabilitiesCurrent
191515
CY2019Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2018Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2019Q3 us-gaap Preferred Stock Value
PreferredStockValue
CY2018Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2019Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
24209
CY2018Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
24051
CY2019Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-5058
CY2018Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-2177
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
22823
CY2019Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
471388
CY2018Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
214338
CY2019Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2019Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2018Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2018Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2019Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2018Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2019Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2018Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
798
CY2019Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
6875000
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
7353480
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
8250000
CY2019Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
0.00
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
0.00
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
0.00
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2019Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1031250
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1237500
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1031250
CY2018Q2 us-gaap Net Income Loss
NetIncomeLoss
-798
CY2018Q2 us-gaap Stockholders Equity
StockholdersEquity
-798
CY2018Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
25000
CY2018Q3 us-gaap Stockholders Equity
StockholdersEquity
24202
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
-801
CY2019Q1 us-gaap Stockholders Equity
StockholdersEquity
22022
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
-1019
CY2019Q2 us-gaap Stockholders Equity
StockholdersEquity
21003
CY2019Q3 us-gaap Stockholders Equity
StockholdersEquity
19942
CY2019Q2 us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
1581250
CY2019Q2 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
0
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
365
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
798
sftwu Business Acquisition Percentage Of Minimum Ownership To Be Acquired
BusinessAcquisitionPercentageOfMinimumOwnershipToBeAcquired
0.50
sftwu Public Shares Redemption Percentage
PublicSharesRedemptionPercentage
1.00
sftwu Minimum Percentage Of Fair Market Value Of Business Acquisition To Trust Account Balance
MinimumPercentageOfFairMarketValueOfBusinessAcquisitionToTrustAccountBalance
0.80
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
91740
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
17500
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-6656
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
7500
CY2018Q3 us-gaap Cash
Cash
7500
sftwu Deferred Offering Costs Included In Accrued Offering Costs
DeferredOfferingCostsIncludedInAccruedOfferingCosts
171966
sftwu Deferred Offering Costs Included In Accrued Offering Costs
DeferredOfferingCostsIncludedInAccruedOfferingCosts
16163
us-gaap Decommissioning Trust Assets Description
DecommissioningTrustAssetsDescription
The Sponsor and the Company’s officers and directors have agreed (a) to waive their redemption rights with respect to their Founder Shares and Public Shares held by them in connection with the completion of a Business Combination and (b) not to propose an amendment to the Company’s Amended and Restated Certificate of Incorporation (a) that would modify the substance or timing of the Company’s obligation to allow redemption in connection with a Business Combination or to redeem 100% of its Public Shares if the Company does not complete a Business Combination or (b) with respect to any other provision relating to stockholders’ rights or pre-initial Business Combination activity, unless the Company provides the public stockholders with the opportunity to redeem their Public Shares in conjunction with any such amendment.
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="font-family: times new roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;;font-style:italic;display:inline;">Concentration of Credit Risk </div></div></div></div><div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Financial instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution, which, at times, may exceed the Federal Depository Insurance Coverage of $250,000. The Company has not experienced losses on this account and management believes the Company is not exposed to significant risks on such account. </div></div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
dei Document Period End Date
DocumentPeriodEndDate
2019-09-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2019
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Entity Registrant Name
EntityRegistrantName
Osprey Technology Acquisition Corp.
dei Security Exchange Name
SecurityExchangeName
NYSE
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Entity Central Index Key
EntityCentralIndexKey
0001753539
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Shell Company
EntityShellCompany
true
dei Security12b Title
Security12bTitle
Units, each consisting of one share of Class A common stock, $0.0001 par value per share, and one-half of one redeemable warrant.
us-gaap Use Of Estimates
UseOfEstimates
<div style="font-family: times new roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;;font-style:italic;display:inline;">Use of Estimates </div></div></div></div><div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">The preparation of the financial statements in conformity with GAAP requires the Company&#8217;s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. </div></div><div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates. </div></div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
18047876
CY2019Q3 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
250000
dei Amendment Flag
AmendmentFlag
false
dei Trading Symbol
TradingSymbol
SFTWU
CY2019Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
39531250
sftwu Description Of Minimum Votes To Be Polled
DescriptionOfMinimumVotesToBePolled
These provisions of the Company&#8217;s Amended and Restated Certificate of Incorporation may only be amended if approved by holders of a majority of at least 90% of the Company&#8217;s common stock voting in a stockholder meeting.
us-gaap Net Income Loss
NetIncomeLoss
-798
us-gaap Revenues
Revenues
0
dei Entity Current Reporting Status
EntityCurrentReportingStatus
No
CY2018Q2 us-gaap Stockholders Equity
StockholdersEquity
sftwu Public Shares Redemption Percentage Threshold
PublicSharesRedemptionPercentageThreshold
0.15
CY2018Q3 us-gaap Net Income Loss
NetIncomeLoss
0
CY2019Q2 us-gaap Stock Issued During Period Value Share Based Compensation Forfeited
StockIssuedDuringPeriodValueShareBasedCompensationForfeited
0
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
0
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
-1061
us-gaap Net Income Loss
NetIncomeLoss
-2881
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-2516
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
0
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
25000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-4140
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
7500
CY2018Q2 us-gaap Cash
Cash
0
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
87600

Files In Submission

Name View Source Status
0001193125-19-311664-index-headers.html Edgar Link pending
0001193125-19-311664-index.html Edgar Link pending
0001193125-19-311664.txt Edgar Link pending
0001193125-19-311664-xbrl.zip Edgar Link pending
d789930d10q.htm Edgar Link pending
d789930dex311.htm Edgar Link pending
d789930dex312.htm Edgar Link pending
d789930dex321.htm Edgar Link pending
d789930dex322.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
sftwu-20190930.xml Edgar Link completed
sftwu-20190930.xsd Edgar Link pending
sftwu-20190930_cal.xml Edgar Link unprocessable
sftwu-20190930_def.xml Edgar Link unprocessable
sftwu-20190930_lab.xml Edgar Link unprocessable
sftwu-20190930_pre.xml Edgar Link unprocessable
Show.js Edgar Link pending